| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/30/2009 | US7553837 Phenylazole compounds production process and antioxidants |
| 06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
| 06/25/2009 | WO2009079490A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 06/25/2009 | WO2009079392A1 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 06/25/2009 | WO2009077844A2 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria |
| 06/25/2009 | WO2009077585A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/25/2009 | WO2009077584A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 06/25/2009 | WO2009077527A1 Anthelmintic agents and their use |
| 06/25/2009 | WO2009077186A1 Nonsteroidal progesterone receptor modulators |
| 06/25/2009 | WO2009076961A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 06/25/2009 | WO2009076747A1 Viral polymerase inhibitors |
| 06/25/2009 | US20090163715 Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090163472 Mineralocorticoid receptor antagonists and methods of use |
| 06/25/2009 | US20090163462 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/25/2009 | US20090163461 Ligand for Vesicular Acetylcholine Transporter |
| 06/25/2009 | DE19532215B4 Verfahren zur Herstellung von 4-Acylamino-2,2,6,6-tetramethylpiperidinen Tetramethylpiperidines 4-acylamino-2,2,6,6-process for the preparation of |
| 06/25/2009 | CA2709407A1 Anthelmintic agents and their use |
| 06/25/2009 | CA2708785A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
| 06/24/2009 | EP2072485A1 Stabilizers for the stabilization of unsaturated hydrocarbon-based precursor |
| 06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
| 06/23/2009 | US7550599 for stabilizing aqueous polymer systems (water borne coatings, aqueous inks, aqueous ink jet media, and photocured aqueous systems) against oxidative, thermal and actinic radiation |
| 06/23/2009 | US7550595 Bronchodilators for treating chronic obstructive pulmonary disease or asthma; long duration of action; e.g. biphenyl-2-ylcarbamic acid 1-(2-([4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino)ethylpiperidin-4-yl ester; dosage forms such as metered dose inhalers |
| 06/23/2009 | US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550486 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/23/2009 | US7550453 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide |
| 06/23/2009 | CA2521029C Process for the preparation of 1,5,-imino, -1,5,6-trideoxy hexitol |
| 06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/18/2009 | WO2009076206A1 Synthesis methods of histone deacetylase inhibitors (hdacis) |
| 06/18/2009 | WO2009075960A1 Ccr5 antagonists as therapeutic agents |
| 06/18/2009 | WO2009075857A2 Glycine transporter-1 inhibitors |
| 06/18/2009 | WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | WO2009016214A3 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/18/2009 | WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 06/18/2009 | US20090156824 Hydroamination of Alkenes |
| 06/18/2009 | US20090156808 Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof |
| 06/18/2009 | US20090156648 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA) |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156623 N-aryl piperidine substituted biphenylcarboxamides |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156441 Cycloalkyl phenylenediamines as deposit control agents for lubricants |
| 06/18/2009 | CA2708734A1 Cycloalkyl phenylenediamines as deposit control agents for lubricants |
| 06/18/2009 | CA2707305A1 Glycine transporter-1 inhibitors |
| 06/18/2009 | CA2706679A1 Novel compounds 010 |
| 06/18/2009 | CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2070909A1 Non-steroidal progesterone receptor modulators |
| 06/17/2009 | EP2069355A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 06/17/2009 | EP2069301A1 Process for the preparation of pleuromutilins |
| 06/17/2009 | EP2069300A2 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 06/17/2009 | EP2069299A2 Anesthetic compounds |
| 06/17/2009 | EP2069291A1 Hdac inhibitors |
| 06/17/2009 | EP1856102B1 Medicaments for alzheimer |
| 06/17/2009 | EP1789410B1 Methylene dipiperidine derivatives |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP0975595B1 Analogs of cocaine |
| 06/17/2009 | CN101460462A Spirocyclic nitriles as protease inhibitors |
| 06/17/2009 | CN101460461A Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids |
| 06/17/2009 | CN101460460A Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists |
| 06/16/2009 | US7547789 Useful in the preparation of modulators of CCR5 chemokine receptor activity; N-(4-piperidinyl)-N-ethyl-4-methanesulfonylphenylacetamide hydrochloride |
| 06/16/2009 | US7547788 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
| 06/16/2009 | US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e |
| 06/16/2009 | US7547701 cathepsin S inhibitors; e.g. N-(1-cyanocyclopropyl)-3-phenylmethanesulfonyl-2-(2,2,2-trifluoro-1-phenylethylamino)-propionamide; autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, pain, or atherosclerosis |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | US7547660 Phenyl-substituted 4-hydroxy-tetrahydropyridones |
| 06/16/2009 | CA2487365C Piperidine derivatives as potassium channel blockers |
| 06/16/2009 | CA2379934C Inhibition of polymerization of ethylenically unsaturated monomers |
| 06/16/2009 | CA2362082C 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and process for the preparation thereof |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009072643A1 Nitrogen-containing heterocyclic compound and use thereof |
| 06/11/2009 | WO2009071658A1 Piperazines as anti-obesity agents |
| 06/11/2009 | WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 06/11/2009 | WO2009070869A1 Renin inhibitors |
| 06/11/2009 | WO2009008920A3 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 06/11/2009 | WO2008125914A3 Process of enantiomeric resolution of d,l-( + )-threo-methylphenidate |
| 06/11/2009 | WO2007135693A3 Intermediates useful for the preparation of antihistaminic piperidine derivative |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149497 Polymorphs of fexofenadine hydrochloride |
| 06/11/2009 | US20090149465 Aminotetralin compounds as mu opioid receptor antagonists |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149443 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090144915 incorporation or grafting of hindered 4-aminopiperidines into a polyolefin, a styrene copolymer or an elastomer; stabilizers for protecting against oxidative, thermal, dynamic, light-induced or ozone-induced degradation; storage stability |
| 06/11/2009 | CA2715527A1 New compounds iv |
| 06/11/2009 | CA2707565A1 Renin inhibitors |
| 06/11/2009 | CA2707555A1 Piperazines as anti-obesity agents |
| 06/11/2009 | CA2706632A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |